FeelGood vs Oak Longevity: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent research·How we rank →

Oak Longevity beats FeelGood overall, scoring 7.5/10 vs 7/10. Oak Longevity is more affordable at $130/mo vs $149/mo. Choose FeelGood for budget-conscious cash-pay patients who want low-cost compoun. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.

A side-by-side comparison of FeelGood and Oak Longevity covering pricing, scores, medication types, insurance, and more to help you decide.

FeelGood

#48 of 49

7/10

Telehealth platform offering compounded semaglutide as both a weekly injection ($149/mo starting) and a daily oral tablet ($249/mo starting), plus a premium brand-name 'original' semaglutide injection option ($1,999/mo). Cash-pay only, no insurance billing, HSA/FSA eligible. LegitScript-approved. FeelGood does not publicly disclose which states it serves, its compounding pharmacy, or its medical leadership.

Visit FeelGood

Higher Rated

Oak Longevity

#26 of 49

7.5/10

Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing — patients pay each month manually rather than auto-renew.

Visit Oak Longevity

Feature	FeelGood	Oak Longevity
Our Score	7/10	7.5/10
Starting Price	$149/mo	$130/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-conscious cash-pay patients who want low-cost compounded semaglutide — injection or oral tablet — with free shipping, no membership fees, and a money-back weight-loss guarantee	Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin)
Ranking	#48	#26

Pros & Cons Compared

FeelGood

Pros

+Compounded semaglutide injection from $149/mo with free shipping and no separate membership or consultation fee
+Offers an oral compounded semaglutide tablet ($249/mo) for needle-averse patients — a non-injectable route only a handful of platforms provide
+LegitScript-approved — independent certification that the telehealth/pharmacy operation meets legal and safety standards, which many budget compounded shops lack
+Money-back weight-loss guarantee plus unlimited 24/7 messaging and appointments included

Cons

−Does NOT publicly disclose which US states it serves — you can't confirm availability in your state before starting an intake
−$149 is a 'starting' price (dose-escalating), not flat across all doses — your cost can rise as your dose titrates up, and FeelGood doesn't publish the full dose-by-dose schedule
−Brand-name 'original' semaglutide injection at $1,999/mo is far above market — NovoCare direct Wegovy is $349/mo and Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership. Never buy brand-name through FeelGood
−No named medical director, prescribing physicians, compounding pharmacy, founding year, or headquarters disclosed on the site — thin corporate and clinical transparency
−Self-reported '4.8/5' rating is not tied to a named third-party platform (no linked Trustpilot/BBB), so it can't be independently verified; the advertised '15–20% weight loss' figures are FeelGood's marketing, not FDA-reviewed efficacy data
−Compounded GLP-1s are not FDA-approved (none are) — and FeelGood offers compounded semaglutide only, no tirzepatide

Oak Longevity

Pros

+$130/mo for compounded semaglutide is among the cheapest entries on the market — Sprout Health ($99) is lower, but Oak undercuts most mid-tier platforms
+Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
+No-subscription model — patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
+Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
+Money-back guarantee if not approved by physician — useful safety net for borderline-eligibility patients
+Free shipping and free health coaching included in every program

Cons

−Brand-name pricing ($1,200-$1,500/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo, LillyDirect Zepbound $299/mo. Never buy brand-name through Oak
−No published lab panels, no specialty (obesity medicine) physicians disclosed — clinical depth is shallow
−'Up to 50% cheaper than competitors' marketing claim is unverified and inconsistent — depends on which competitor and which medication tier
−'Longevity' framing pushes users toward add-on products (NAD+, Sermorelin, Tesamorelin) that have limited clinical evidence for weight loss specifically
−Newer brand without disclosed company history, founding date, or executive team on landing pages
−Three-month plans are billed upfront — pricing transparency is good, but commit-up-front is a friction point for users testing the platform

Our Verdict

Oak Longevity edges out FeelGood with a score of 7.5/10 vs 7/10. If budget is your priority, Oak Longevity starts at $130/mo compared to FeelGood's $149/mo. Choose FeelGood if you want: budget-conscious cash-pay patients who want low-cost compounded semaglutide — injection or oral tablet — with free shipping, no membership fees, and a money-back weight-loss guarantee. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither FeelGood nor Oak Longevity feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review